KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Finished Goods (2016 - 2026)

ClearPoint Neuro's Finished Goods history spans 13 years, with the latest figure at $4.8 million for Q4 2025.

  • On a quarterly basis, Finished Goods rose 32.99% to $4.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $4.8 million, a 32.99% increase, with the full-year FY2025 number at $4.8 million, up 32.99% from a year prior.
  • Finished Goods hit $4.8 million in Q4 2025 for ClearPoint Neuro, up from $3.5 million in the prior quarter.
  • Over the last five years, Finished Goods for CLPT hit a ceiling of $4.8 million in Q4 2025 and a floor of $664000.0 in Q1 2025.
  • Historically, Finished Goods has averaged $2.4 million across 4 years, with a median of $1.6 million in 2021.
  • Biggest five-year swings in Finished Goods: fell 15.07% in 2021 and later soared 193.27% in 2024.
  • Tracing CLPT's Finished Goods over 4 years: stood at $1.4 million in 2021, then dropped by 13.04% to $1.2 million in 2023, then soared by 193.27% to $3.6 million in 2024, then soared by 32.99% to $4.8 million in 2025.
  • Business Quant data shows Finished Goods for CLPT at $4.8 million in Q4 2025, $3.5 million in Q3 2025, and $3.4 million in Q2 2025.